title: Ketamine - A Multifaceted Drug.
abstract: There is a petition for tight control of ketamine from the Chinese government to classify ketamine as a Schedule I drug, which is defined as a drug with no currently accepted medical use but a high potential for abuse. However, ketamine has unique properties that can benefit different patient populations. Scholars from the Translational Perioperative and Pain Medicine and the International Chinese Academy of Anesthesiology WeChat groups had an interactive discussion on ketamine, including its current medical applications, future research priorities, and benefits versus risks. The discussion is summarized in this manuscript with some minor edits.
authors.affiliation: Department of Anesthesia and Perioperative Care, University of California San Francisco.
authors.forename: Lingzhong
authors.initials: L
authors.lastname: Meng
authors.affiliation: The 1 Affiliated Hospital of Soochow University, China.
authors.forename: Jian
authors.initials: J
authors.lastname: Li
authors.affiliation: School of Medicine, University of California San Francisco.
authors.forename: Yi
authors.initials: Y
authors.lastname: Lu
authors.affiliation: Department of Anesthesiology, Renji Hospital, Jiaotong University School of Medicine.
authors.forename: Dajin
authors.initials: D
authors.lastname: Sun
authors.affiliation: Department of Anesthesiology, Rutgers New Jersey Medical School, The State University of New Jersey.
authors.forename: Yuan-Xiang
authors.initials: YX
authors.lastname: Tao
authors.affiliation: Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania.
authors.forename: Renyu
authors.initials: R
authors.lastname: Liu
authors.affiliation: Departments of Neurology and Pharmacology, Temple University.
authors.forename: Jin Jun
authors.initials: JJ
authors.lastname: Luo